Menu
April 10, 2017 | Evidence into Practice
The AONN+ Evidence into Practice Committee would like to extend thanks to all who responded to our recent survey in order to glean members’ knowledge and comfort level in quality, outcomes, performance improvement, and research projects that can be considered research in the broad sense of the word.
April 10, 2017 | Evidence into Practice
New to quality improvement and research and want to know how to begin? The AONN+ Mentorship Workgroup of the Evidence into Practice Committee have made it simple for you.
April 6, 2017 | Evidence into Practice
The role of the navigator along the continuum of care is bidimensional in nature with a patient-centered (empowerment with education and knowledge) and health system (multidisciplinary) orientation to deliver timely, seamless care. Within the multidisciplinary team, the navigator works as an advocate, care provider, educator, counselor, and facilitator to ensure that every patient receives comprehensive, timely, and quality healthcare services.
April 19, 2016 | Evidence into Practice
The scope of navigation has evolved from the Freeman model of community outreach and prevention to spanning the entire continuum of care for oncology patients. Navigators help individuals overcome barriers to care and navigate through the screening/diagnostic, treatment, survivorship, and end-of-life care continuum.
April 19, 2016 | Evidence into Practice
The case study for this discussion highlights the complexities of care coordination when patients arrive unprepared physically or mentally for the recommended medical treatments as determined by guidelines. It also shows how navigators can assemble needed care team players to efficiently guide the patient through prehabilitation and preparation for medical treatment.
Along with the diagnosis of breast cancer comes many decisions regarding treatment options. Oncotype DX, a genomic/gene expression assay, provides quantitative assessment of chemotherapy benefit and risk of distant recurrence in early-stage estrogen receptor–positive (ER+), HER2/neu-negative breast cancer to assist in developing individualized treatment plans.
January 14, 2016 | Evidence into Practice
In 1990, Harold P. Freeman, MD, noticed that African American women in the Harlem community had a higher incidence of breast cancer mortality.
In this community outreach example, the daunting challenges of treatment, and the impact on quality of life, drive the questions, “How can we better serve these patients?” and “Is there anything we can do to prevent or detect head and neck cancers earlier?”
January 14, 2016 | Evidence into Practice
Along the continuum of cancer care for many patient populations, navigators play an essential role in community outreach and prevention. To be effective, navigators must have core knowledge of the early signs of cancer, and the current screening guidelines, as well as the available community and state resources for screening and diagnostics.

Results 1 - 9 of 9

Thank you to our Corporate Sponsors!

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Cornerstone Corporate Sponsor

    Cornerstone Corporate Sponsor

  • Cornerstone Corporate Sponsor

    Cornerstone Corporate Sponsor

  • Industry Relations Council Member

    Industry Relations Council Member

  • Industry Relations Council Member

    Industry Relations Council Member